Understanding the challenges of extractables and leachables for the pharmaceutical industry - Safety and regulatory environment for pharmaceuticals

American Pharmaceutical Review

Volumn 10, Issue 1, 2007, Pages 32-39

  Norwood, Daniel L ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; GAS CHROMATOGRAPHY; GOOD MANUFACTURING PRACTICE; ION PAIR CHROMATOGRAPHY; LEACHING; MASS SPECTROMETRY; PROCESS DESIGN; REVIEW;

EID: 43349105461     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Hopkins, J. L.; Cohen, K. A.; Hatch, F. W.; Pitner, T. P.; Stevenson, J. M.; Hess, F. K. Pharmaceuticals: Tracking Down an Unidentified Trace Level Constituent. Anal. Chem. 1987, 59(11), 784A-786A, 788A, 790A.
2. Kiang, P. H. The Application of Gas Chromatography/Mass Spectrometry to the Analysis of Pharmaceutical Packaging Materials. J. Parent. Sci. Technol. 1981, 35 (4), 152-161.
3. Norwood, D. L.; Paskiet, D. M.; Granger, A. T. Extractables and Leachables in Drugs and Packaging. In: The Encyclopedia of Pharmaceutical Technology (J. Swarbrick, Ed.), 3rd Edition, in press 2006.
4. Container Closure Systems for Packaging Human Drugs and Biologics; Guidance for Industry; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CEDER) and Center for Biologics Evaluation and Research (CBER); Rockville, MD, May 1999; 1-41.
5. Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products; Draft Guidance for Industry; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CEDER); Rockville, MD, October 1998; 1-62.
6. Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products - Chemistry, Manufacturing, and Controls Documentation; Guidance for Industry; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CEDER); Rockville, MD, July 2002; 1-45.
7. Norwood, D. L.; Nagao, L.; Lyapustina, S.; Munos, M. Application of Modern Analytical Technologies to the Identification of Extractables and Leachables. Am. Pharm. Rev.. 2005, 8 (1), 78-87.
8. Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products, PQRI Leachables and Extractables Working Group, available at http://www.pqri.org/pdfs/LE_Recommendations_to_FDA_09-29- 06.pdf (accessed November 2006).
9. Leachables and Extractables Testing: Points to Consider, IPAC-RS March 2001, available at http://www.ipacrs.com/leachables.html (accessed March 2005).
10. Yu, L. X. Implementation of Quality-by-Design: Question-based Review. 42nd Annual Meeting Drug Information Association; Philadelphia, 2006.
11. Nasr, M. M. Risk-Based CMC Review and Quality Assessment: What is Quality by Design (QbD)? 2006 FDA/Industry Conference; School of Pharmacy - Temple University; March 29, 2006.
12. Juran, J.M. Juran on Quality by Design. The Free Press; New York, 1992.
13. Barker, T. B. Quality by Experimental Design. Marcel Dekker; New York, 1994.
14. Barker, T.B. Engineering Quality by Design - Interpreting the Taguchi Approach. Marcel Dekker; New York, 1990.
15. ICH Harmonized Tripartite Guideline: Pharmaceutical Development Q8. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; Current Step 4 Version; dated 10 November 2005.
16. Tougas, T. IPAC-RS Model OINDP Initiative. IPAC-RS 2006 Conference Inhalation and Nasal Drugs: The Regulatory Landscape. North Bethesda, MD, November 6-8, 2006.
17. Norwood, D. L.; Prime, D.; Downey, B. P.; Creasey, J.; Satinder, S. K.; Haywood, P. Analysis of Polycyclic Aromatic Hydrocarbons in Metered Dose Inhaler Drug Formulations by Isotope Dilution Gas Chromatography/Mass Spectrometry. J. Pharm. Biomed. Anal., 1995, 13 (3), 293-304.
18. Popper, K.; The Logic of Scientific Discovery, 1st Ed.; Routledge Classics: London, 2003.
19. Good Manufacturing Practices Guideline for Suppliers of Components for Orally Inhaled and Nasal Drug Products, IPAC-RS 2006, further information available at http://www.ipacrs.com (accessed November 2006).